What laboratory tests are recommended for diagnosing malabsorption?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Tests for Malabsorption

A basic screen for evidence of malabsorption should include full blood count, urea and electrolytes, liver function tests, vitamin B12, folate, calcium, ferritin, erythrocyte sedimentation rate, and C-reactive protein, with mandatory serological testing for coeliac disease in all patients presenting with suspected malabsorption. 1

Initial Blood Tests

The British Society of Gastroenterology provides clear guidance on the essential initial laboratory workup 1:

  • Complete blood count (CBC): Identifies anaemia, which has high specificity for organic disease when present alongside other abnormalities 1
  • Iron studies (ferritin, serum iron): Iron deficiency is a sensitive indicator of small bowel enteropathy, particularly coeliac disease 1
  • Vitamin B12 and folate: Essential markers of malabsorption, particularly in small bowel disease 1
  • Calcium: Screens for malabsorption of fat-soluble nutrients 1
  • Liver function tests: Detects hepatobiliary involvement and albumin levels 1
  • Urea and electrolytes: Assesses for dehydration and electrolyte disturbances 1
  • Inflammatory markers (ESR, CRP): Abnormal results combined with anaemia or low albumin have high specificity for organic disease 1
  • Thyroid function tests (TSH): Hyperthyroidism can cause diarrhoea and must be excluded 1

Mandatory Coeliac Disease Screening

Serological testing for coeliac disease is mandatory in all patients with suspected malabsorption, given that coeliac disease affects 0.5-1% of the population and is present in 3-10% of patients with chronic diarrhoea referred to secondary care 1, 2:

  • Anti-endomysial antibody (EMA): Preferred first-line test 2
  • Anti-tissue transglutaminase IgA (anti-TG2 IgA): Alternative first-line option 1
  • If serological tests are negative but malabsorption is still suspected, upper gastrointestinal endoscopy with distal duodenal biopsies should be performed 2, 3

Additional Micronutrient Assessment

Beyond the basic screen, additional testing should be considered based on clinical context 1:

  • Vitamin D (25-hydroxyvitamin D): Deficiency occurs in 16-95% of patients with malabsorption, particularly in inflammatory bowel disease 1
  • Fat-soluble vitamins (A, E, K): Particularly important in patients with fat malabsorption 1
  • Magnesium and phosphorus: Essential for metabolic bone disease assessment 1
  • Vitamin B6, vitamin C, zinc, selenium: Consider in patients with small bowel disease, previous resection, or those receiving nutritional supplementation 1

Specialized Testing for Specific Scenarios

Pancreatic Insufficiency

  • Stool elastase: Preferred over older methods for suspected pancreatic insufficiency 2

Fat Malabsorption

  • Avoid quantitative 3-day faecal fat collection: Poor reproducibility, unpleasant, and non-diagnostic 2
  • Breath tests using 14C-triolein or 13C-labeled mixed triglyceride have low sensitivity for mild/moderate fat malabsorption but may serve as alternatives where available 2

Carbohydrate Malabsorption

  • Hydrogen breath tests: Offer better diagnostic value for specific carbohydrate intolerances than stool pH or reducing substances 2

Monitoring Frequency in Established Malabsorption

For patients with known small bowel disease or previous resection 1:

  • Vitamin B12 and folic acid: Every 3-6 months 1
  • Anaemia screening (CBC, ferritin, CRP): Every 3 months in symptomatic patients 1
  • Bone density assessment: Every 2-3 years in short bowel syndrome patients 1

Critical Interpretation Pitfalls

  • Ferritin in active inflammation: Values up to 100 μg/L may still indicate iron deficiency in active disease, especially with transferrin saturation <20% 1
  • Albumin is NOT an appropriate test for malabsorption: It is an acute phase protein that does not correlate with nutritional status in otherwise healthy individuals 1
  • Coeliac serology has poor sensitivity (11.8-30%) for detecting persistent mucosal damage in patients already on a gluten-free diet 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approaches for Malabsorption

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach to Rule Out Malabsorption in Patients Taking Levothyroxine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.